Our medium-term Stockgrader too is off to a great start. More than 80% of the companies with Final Grade A were up, some very sharply. Here is a review
The first issue in which we offered medium-term buys had just 13 stocks with a final Grade A. Of these 12 were up and just one was down. The best performer was Glenmark Pharmaceuticals, probably India’s best pharma company, which is extremely...
As we reported last time, the Zee group is among the big corporates that got away with a mere warning from the SEBI whole-time member, TC Nair, for its role in the Ketan Parekh scam, despite copious evidence of its extraordinary fund transfers through accounts in Global Trust Bank (GTB). We now learn that the Zee group had actually indicated to SEBI officials that they would be willing to pay...
Gammon India: On 19th April, a financial daily reported that Gammon India had bagged a Rs800 crore order to develop 15 acres of land. The share price jumped on the news. In an interesting response, Gammon pointed out that the paper had exaggerated the size of the order, which was for Rs338 crore “and not Rs800 crore, as has been wrongly stated in the media.” It put things in perspective...
